Thrive Dispensaries, operated by MariMed Inc., awarded $20,000 through its Help on the Homefront campaign to support veterans facing housing challenges. Four veterans from Maryland, Massachusetts, Delaware, and Illinois each received $5,000 to help with rent, mortgage, or home improvements. This initiative highlights the ongoing housing struggles veterans face and reflects Thrive's commitment to community support. The program, now in its third year, aims to ease financial burdens and provide stability for veterans nationwide.
Thrive Dispensaries' support for veterans is the story's subject, with this market snapshot from Pluang for context. For readers following Consumer Cyclical stocks, here is Pluang's market snapshot as of Nov 11, 2026 17:31 WIB: out of 134 priced US stocks, 48 rose and 75 fell today. Notable movers include PRTS at USD 7.88 with a 1-day change of -5.63% and a typical hold time of 46 days, TDUP at USD 1.55 with a 1-day change of +4.03%, typical hold time 29 days, and Pluang order activity showing 56% sell and 44% buy, and PLBY at USD 1.22 with a 1-day change of -3.94%, typical hold time 25 days, with Pluang order activity 0% sell and 100% buy.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
